Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands

被引:64
作者
van Rijn, Anne F. [2 ]
Fockens, Paul [2 ]
Siersema, Peter D. [1 ]
Oldenburg, Bas [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, NL-3584 CX Utrecht, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol Hepatol, NL-1105 AZ Amsterdam, Netherlands
关键词
Colorectal cancer; Crohn's disease; Dysplasia; Guidelines; Surveillance; Ulcerative colitis; CANCER; DISEASE; RISK; UPDATE;
D O I
10.3748/wjg.15.226
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study adherence to the widely accepted surveillance guidelines for patients with long-standing colitis in the Netherlands. METHODS: A questionnaire was sent to all 244 gastroenterologists in the Netherlands. RESULTS: The response rate was 63%. Of all gastroenterologists, 95% performed endoscopic surveillance in ulcerative colitis (UC) patients and 65% in patients with Crohn's colitis. The American Gastroenterological Association (AGA) guidelines were followed by 27%, while 27% and 46% followed their local hospital protocol or no specific protocol, respectively. The surveillance was correctly initiated in cases of pancolitis by 53%, and in cases of left-sided colitis by 44% of the gastroenterologists. Although guidelines recommend 4 biopsies every 10 cm, less than 30 biopsies per colonoscopy were taken by 73% of the responders. Only 31%, 68% and 58% of the gastroenterologists referred patients for colectomy when low-grade dysplasia, high-grade dysplasia (HGD) or Dysplasia Associated Lesion or Mass (DALM) was present, respectively. CONCLUSION: Most Dutch gastroenterologists perform endoscopic surveillance without following international recommended guidelines. This practice potentially leads to a decreased sensitivity for dysplasia, rendering screening for colorectal cancer in this population highly ineffective. (c) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:226 / 230
页数:5
相关论文
共 14 条
  • [1] BERNSTEIN CN, 1995, AM J GASTROENTEROL, V90, P2106
  • [2] Cummings SM, 2001, HEALTH SERV RES, V35, P1347
  • [3] Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis
    Eaden, J
    Abrams, K
    McKay, H
    Denley, H
    Mayberry, J
    [J]. JOURNAL OF PATHOLOGY, 2001, 194 (02) : 152 - 157
  • [4] How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance
    Eaden, JA
    Ward, BA
    Mayberry, JF
    [J]. GASTROINTESTINAL ENDOSCOPY, 2000, 51 (02) : 123 - 128
  • [5] Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease
    Eaden, JA
    Mayberry, JF
    [J]. GUT, 2002, 51 : V10 - V12
  • [6] The risk of colorectal cancer in ulcerative colitis: a meta-analysis
    Eaden, JA
    Abrams, KR
    Mayberry, JF
    [J]. GUT, 2001, 48 (04) : 526 - 535
  • [7] INCREASED RISK OF LARGE-BOWEL CANCER IN CROHNS-DISEASE WITH COLONIC INVOLVEMENT
    EKBOM, A
    HELMICK, C
    ZACK, M
    ADAMI, HO
    [J]. LANCET, 1990, 336 (8711) : 357 - 359
  • [8] ULCERATIVE-COLITIS AND COLORECTAL-CANCER - A POPULATION-BASED STUDY
    EKBOM, A
    HELMICK, C
    ZACK, M
    ADAMI, HO
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) : 1228 - 1233
  • [9] Surveillance for dysplasia in patients with inflammatory bowel disease: A national survey of colonoscopic practice in New Zealand
    Gearry, RB
    Wakeman, CJ
    Barclay, ML
    Chapman, BA
    Collett, JA
    Burt, MJ
    Frizelle, FA
    [J]. DISEASES OF THE COLON & RECTUM, 2004, 47 (03) : 314 - 322
  • [10] ULCERATIVE-COLITIS AND CROHNS-DISEASE - A COMPARISON OF THE COLORECTAL-CANCER RISK IN EXTENSIVE COLITIS
    GILLEN, CD
    WALMSLEY, RS
    PRIOR, P
    ANDREWS, HA
    ALLAN, RN
    [J]. GUT, 1994, 35 (11) : 1590 - 1592